Tribune Therapeutics
Latest round
- Series A
Last raised
- Mar 2025
Total raised
- $25M
Investors
- 7
About Tribune Therapeutics
Based in Stockholm, Sweden, and founded in 2020, Tribune Therapeutics AB operates as a preclinical biopharmaceutical company. The company was founded by its CSO, Ole Kaasbøll. Tribune Therapeutics uses a pan-antifibrotic mechanism to develop a wide range of novel medicines to treat patients with fibrotic diseases. The company offers new medicines for fibrotic diseases, like liver fibrosis, kidney fibrosis, and lung fibrosis. The firm’s advanced candidate, TRX-44, is a protein therapeutic that targets CCN signaling. TRX-44 works by interfering with activated pro-fibrotic CCN domains, thereby blocking fibrotic signaling. This prevents the replacement of healthy tissue with scar tissue.
Who invested in Tribune Therapeutics
7 investors across 2 rounds
See all investors in Tribune Therapeutics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Tribune Therapeutics
Who invested in Tribune Therapeutics?
Tribune Therapeutics has 7 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Tribune Therapeutics raised?
Tribune Therapeutics has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Tribune Therapeutics last raise money?
Tribune Therapeutics's most recent round on record is a Series A, in Mar 2025.
What does Tribune Therapeutics do?
Based in Stockholm, Sweden, and founded in 2020, Tribune Therapeutics AB operates as a preclinical biopharmaceutical company.
Where is Tribune Therapeutics headquartered?
Tribune Therapeutics is headquartered in Stockholm, Sweden.
Which VCs invest in companies like Tribune Therapeutics?
Among active investors with capital left to deploy, Index Ventures, Forbion, European Investment Bank and Highland Europe back biotechnology companies at Tribune Therapeutics's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like Tribune Therapeutics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.